ロード中...
What’s Next After Anamorelin?
PURPOSE: In spite of its relevance, treatments for the cancer anorexia and cachexia syndrome (CACS) are not available. One of the agents that recently reached phase III clinical trials is anamorelin. Its development, along with that of other agents for this indication will be reviewed here, with a f...
保存先:
| 出版年: | Curr Opin Support Palliat Care |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5776683/ https://ncbi.nlm.nih.gov/pubmed/28957883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SPC.0000000000000299 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|